Lodenosine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Lodenosine
Lodenosine.png
Names
IUPAC name
[(2S,4S,5R)-5-(6-Aminopurin-9-yl)-4-fluorooxolan-2-yl]methanol
Identifiers
3D model (JSmol)
ChemSpider
KEGG
UNII
Properties
C10H12FN5O2
Molar mass 253.23 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

Lodenosine is a failed experimental agent for the treatment of HIV. Its development was discontinued on January 11, 2001.[1]

References[edit]

  1. ^ "Drug Profile: Lodenosine". AdisInsight. Adis International Ltd, part of Springer Science+Business Media. Retrieved 4 December 2015.